Golden Autumn Sending cool, fruitful.As one of the 2024 pink ribbons, Peking University Hospital (hereinafter referred to as Shougang Hospital) Diagnosis and treatment progress and multidisciplinary case discussion will be Hold on the day.Professor Moxelley of Shougang Hospital and Professor Song Guohong of Peking University Cancer Hospital as the executive chairman of the conference, Professor Jiang Zefei, deputy director of the Department of Cancer Medical Department of the General Hospital of the PLA, Professor Michael Gnant, executive chairman of the St. Gallen International Breast Cancer Conference. Wang Yilin, Director of the Department of Breast Diseases of Shougang Hospital, Wang Yunfan, director of the Department of Pathology, and Ren Gang, director of the Department of Radio, participated in the discussion.
At present, the sick group of breast cancer is becoming increasingly larger. With the popularity of multidisciplinary diagnosis and treatment (MDT) mode The concept of precise and evidence -based penetration through the practice of clinical diagnosis and treatment, the cure rate and survival rate of breast cancer have increased significantly.In the context of precision medicine, the diagnosis and treatment of breast cancer are changing with each passing day, and development and challenges coexist.The conference set up a platform to promote cross -disciplinary cooperation and exchanges in international, provincial, and hospitals.
The conference "cutting-edge progress, standardized diagnosis and treatment", Professor Wang Jilin of Shougang Hospital Hui Tong Shandong University Second Hospital, Qingdao University Affiliated Hospital, Affiliated Hospital of Qingdao University, Experts at the First Affiliated Hospital of Xian Jiaotong University, the Second Affiliated Hospital of Dalian Medical University, and experts from the Affiliated Hospital of Inner Mongolia Medical University were chaired.Three experts from the First Medical Center of the General Hospital of the Peoples Liberation Army, Affiliated Hospital of Hebei University, Peking University Hospitals three experts around Her2-positive breast cancer treatment consensus and disputes, HER2-positive breast cancer treatment progress progress A wonderful report was optimized and the HR positive endocrine therapy was given.
In the "Case MDT" session, Dr. Han Dong, Shougang Hospital, Dr. Xiao Jinyi, Fifth Medical Center of the General Hospital of the PLA, and Dr. Zhang Ruyan, Peking University Cancer Hospital, shared HR positive HER2 low expression breast cancer. Her2 -positive breast cancer brain metastasis and Sanyin breast cancer sharing with participating experts shared with the participating experts to promote academic collision and integration.
The meeting also specially invited Professor Michael Gnant from the St. Gallen International Breast Cancer Conference (SGBCC) to analyze the cutting-edge of digital pathology science Progress, the innovation application of outpost lymph nodes, the treatment strategies of micro -transfer lesions, and current hot topics such as radiation and chemotherapy and endocrine therapy.In the interactive link of "Chinese and foreign experts", Professor Michael Gnant launched a heated discussion and collision with the participating experts.
The successful holding of this meeting has established a platform for communication and learning for experts and scholars in the field of breast cancer, promoting multi-disciplinary cooperation and domestic domestic collaboration and domestic Diplomacy.It is believed that with the joint efforts of everyone, the level of breast cancer diagnosis and treatment will continue to improve, and more patients will benefit from it.
Text: Fan Zhenhua, Division of Breast Diseases
Editor: Party Committee Office
